Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial updates report on the efficacy and safety of insulin detemir in combination with insulin aspart and biphasic insulin aspart 30 in adults with type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoLog (insulin aspart)
• NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart mix 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED